2002 News

September 30, 2002

Morphotek Receives Pennsylvania Opportunity Grant to Support Ongoing Research and Development
Read More

September 26, 2002

Morphotek Announces Delivery of Evolved Cell Line to Wyeth Pharmaceuticals for Target Discovery
Read More

July 23, 2002

Morphotek Receives Army Grant to Support Development of High Titer Production Strains for the Generation of Therapeutic Polypeptides
Read More

June 18, 2002

Morphotek Announces the Appointment of Rodney Dausch as Vice President and Chief Financial Officer
Read More

May 23, 2002

Morphotek Expands Operations and Relocates to New Facility in Exton, PA.
Read More

April 30, 2002

Morphotek and the Ludwig Institute for Cancer Research Announce Collaborative Research Agreement to Develop Therapeutical Monoclonal Antibodies for the Treatment of Cancer
Read More

March 27, 2002

Morphotek Receives Ben Franklin Emerging Business Biotech Company Of The Year Award
Read More

February 6, 2002

Morphotek And The Wistar Institute Announce Collaborative Research Agreement On Monoclonal Antibodies
Read More

February 2, 2002

Morphotek Announces Appointment To Senior Management
Read More

January 21, 2002

David R. King Joins Morphotek Board Of Directors
Read More